QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (191) Citing Articles via Google Scholar Google Scholar Articles by Sherer, T. B. Articles by Greenamyre, J. T. Search for Related Content PubMed PubMed Citation Articles by Sherer, T. B. Articles by Greenamyre, J. T.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 15, 2002, 22(16):7006-7015

An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered -Synuclein Metabolism and Oxidative Damage

Todd B. Sherer¹, Ranjita Betarbet¹, Amy K. Stout¹, Serena Lund¹, Melisa Baptista², Alexander V. Panov¹, Mark R. Cookson², and J. Timothy Greenamyre¹

¹ Center for Neurodegenerative Disease and Department of Neurology, Emory University, Atlanta, Georgia 30322, and ² National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892

Chronic systemic complex I inhibition caused by rotenone exposure induces features of Parkinson's disease (PD) in rats, including selective nigrostriatal dopaminergic degeneration and formation of ubiquitin- and -synuclein-positive inclusions (Betarbet et al., 2000). To determine underlying mechanisms of rotenone-induced cell death, we developed a chronic in vitro model based on treating human neuroblastoma cells with 5 nM rotenone for 1-4 weeks. For up to 4 weeks, cells grown in the presence of rotenone had normal morphology and growth kinetics, but at this time point, ~5% of cells began to undergo apoptosis. Short-term rotenone treatment (1 week) elevated soluble -synuclein protein levels without changing message levels, suggesting that -synuclein degradation was retarded. Chronic rotenone exposure (4 weeks) increased levels of SDS-insoluble -synuclein and ubiquitin. After a latency of >2 weeks, rotenone-treated cells showed evidence of oxidative stress, including loss of glutathione and increased oxidative DNA and protein damage. Chronic rotenone treatment (4 weeks) caused a slight elevation in basal apoptosis and markedly sensitized cells to further oxidative challenge. In response to H₂O₂, there was cytochrome c release from mitochondria, caspase-3 activation, and apoptosis, all of which occurred earlier and to a much greater extent in rotenone-treated cells; caspase inhibition provided substantial protection. These studies indicate that chronic low-grade complex I inhibition caused by rotenone exposure induces accumulation and aggregation of -synuclein and ubiquitin, progressive oxidative damage, and caspase-dependent death, mechanisms that may be central to PD pathogenesis.

Key words: -synuclein; cytochrome c; glutathione; caspase-3; carbonyls; ubiquitin

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/22167006-10$05.00/0

This article has been cited by other articles:

				M. Shi, J. Bradner, T. K. Bammler, D. L. Eaton, J. Zhang, Z. Ye, A. M. Wilson, T. J. Montine, C. Pan, and J. Zhang Identification of Glutathione S-Transferase Pi as a Protein Involved in Parkinson Disease Progression Am. J. Pathol., July 1, 2009; 175(1): 54 - 65. [Abstract] [Full Text] [PDF]

				H. Bayir, A. A. Kapralov, J. Jiang, Z. Huang, Y. Y. Tyurina, V. A. Tyurin, Q. Zhao, N. A. Belikova, I. I. Vlasova, A. Maeda, et al. Peroxidase Mechanism of Lipid-dependent Cross-linking of Synuclein with Cytochrome c: PROTECTION AGAINST APOPTOSIS VERSUS DELAYED OXIDATIVE STRESS IN PARKINSON DISEASE J. Biol. Chem., June 5, 2009; 284(23): 15951 - 15969. [Abstract] [Full Text] [PDF]

				W.-S. Choi, S. E. Kruse, R. D. Palmiter, and Z. Xia Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat PNAS, September 30, 2008; 105(39): 15136 - 15141. [Abstract] [Full Text] [PDF]

				C. Costa, V. Belcastro, A. Tozzi, M. Di Filippo, M. Tantucci, S. Siliquini, A. Autuori, B. Picconi, M. G. Spillantini, E. Fedele, et al. Electrophysiology and Pharmacology of Striatal Neuronal Dysfunction Induced by Mitochondrial Complex I Inhibition J. Neurosci., August 6, 2008; 28(32): 8040 - 8052. [Abstract] [Full Text] [PDF]

				C. Press and J. Milbrandt Nmnat Delays Axonal Degeneration Caused by Mitochondrial and Oxidative Stress J. Neurosci., May 7, 2008; 28(19): 4861 - 4871. [Abstract] [Full Text] [PDF]

				M. Marella, B. B. Seo, A. Matsuno-Yagi, and T. Yagi Mechanism of Cell Death Caused by Complex I Defects in a Rat Dopaminergic Cell Line J. Biol. Chem., August 17, 2007; 282(33): 24146 - 24156. [Abstract] [Full Text] [PDF]

				H. Fukui and C. T. Moraes Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates Hum. Mol. Genet., April 1, 2007; 16(7): 783 - 797. [Abstract] [Full Text] [PDF]

				M. Smeyne, J. Boyd, K. Raviie Shepherd, Y. Jiao, B. B. Pond, M. Hatler, R. Wolf, C. Henderson, and R. J. Smeyne GST{pi} expression mediates dopaminergic neuron sensitivity in experimental parkinsonism PNAS, February 6, 2007; 104(6): 1977 - 1982. [Abstract] [Full Text] [PDF]

				S. Murase and R. D. McKay A specific survival response in dopamine neurons at most risk in Parkinson's disease. J. Neurosci., September 20, 2006; 26(38): 9750 - 9760. [Abstract] [Full Text] [PDF]

				Y. Yang, S. Gehrke, Y. Imai, Z. Huang, Y. Ouyang, J.-W. Wang, L. Yang, M. F. Beal, H. Vogel, and B. Lu Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin PNAS, July 11, 2006; 103(28): 10793 - 10798. [Abstract] [Full Text] [PDF]

				J. Jin, C. Hulette, Y. Wang, T. Zhang, C. Pan, R. Wadhwa, and J. Zhang Proteomic Identification of a Stress Protein, Mortalin/mthsp70/GRP75: Relevance To Parkinson Disease Mol. Cell. Proteomics, July 1, 2006; 5(7): 1193 - 1204. [Abstract] [Full Text] [PDF]

				R. Ved, S. Saha, B. Westlund, C. Perier, L. Burnam, A. Sluder, M. Hoener, C. M. P. Rodrigues, A. Alfonso, C. Steer, et al. Similar Patterns of Mitochondrial Vulnerability and Rescue Induced by Genetic Modification of {alpha}-Synuclein, Parkin, and DJ-1 in Caenorhabditis elegans J. Biol. Chem., December 30, 2005; 280(52): 42655 - 42668. [Abstract] [Full Text] [PDF]

				A. Panov, S. Dikalov, N. Shalbuyeva, G. Taylor, T. Sherer, and J. T. Greenamyre Rotenone Model of Parkinson Disease: MULTIPLE BRAIN MITOCHONDRIA DYSFUNCTIONS AFTER SHORT TERM SYSTEMIC ROTENONE INTOXICATION J. Biol. Chem., December 23, 2005; 280(51): 42026 - 42035. [Abstract] [Full Text] [PDF]

				C. Wang, H. S. Ko, B. Thomas, F. Tsang, K. C.M. Chew, S.-P. Tay, M. W.L. Ho, T.-M. Lim, T.-W. Soong, O. Pletnikova, et al. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function Hum. Mol. Genet., December 15, 2005; 14(24): 3885 - 3897. [Abstract] [Full Text] [PDF]

				L. Silvestri, V. Caputo, E. Bellacchio, L. Atorino, B. Dallapiccola, E. M. Valente, and G. Casari Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism Hum. Mol. Genet., November 15, 2005; 14(22): 3477 - 3492. [Abstract] [Full Text] [PDF]

				S. H. Wilson and W. A. Suk Framework For Environmental Exposure Research: The Disease-First Approach Mol. Interv., October 1, 2005; 5(5): 262 - 267. [Full Text] [PDF]

				A. M. Celotto and M. J. Palladino Drosophila: A "Model" Model System To Study Neurodegeneration Mol. Interv., October 1, 2005; 5(5): 292 - 303. [Abstract] [Full Text] [PDF]

				S. Kaul, V. Anantharam, Y. Yang, C. J. Choi, A. Kanthasamy, and A. G. Kanthasamy Tyrosine Phosphorylation Regulates the Proteolytic Activation of Protein Kinase C{delta} in Dopaminergic Neuronal Cells J. Biol. Chem., August 5, 2005; 280(31): 28721 - 28730. [Abstract] [Full Text] [PDF]

				J. Callio, T. D. Oury, and C. T. Chu Manganese Superoxide Dismutase Protects against 6-Hydroxydopamine Injury in Mouse Brains J. Biol. Chem., May 6, 2005; 280(18): 18536 - 18542. [Abstract] [Full Text] [PDF]

				F. Zoccarato, P. Toscano, and A. Alexandre Dopamine-derived Dopaminochrome Promotes H2O2 Release at Mitochondrial Complex I: STIMULATION BY ROTENONE, CONTROL BY Ca2+, AND RELEVANCE TO PARKINSON DISEASE J. Biol. Chem., April 22, 2005; 280(16): 15587 - 15594. [Abstract] [Full Text] [PDF]

				D. J. Moore, L. Zhang, J. Troncoso, M. K. Lee, N. Hattori, Y. Mizuno, T. M. Dawson, and V. L. Dawson Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress Hum. Mol. Genet., January 1, 2005; 14(1): 71 - 84. [Abstract] [Full Text] [PDF]

				G.-R. Kweon, J. D. Marks, R. Krencik, E. H. Leung, P. T. Schumacker, K. Hyland, and U. J. Kang Distinct Mechanisms of Neurodegeneration Induced by Chronic Complex I Inhibition in Dopaminergic and Non-dopaminergic Cells J. Biol. Chem., December 10, 2004; 279(50): 51783 - 51792. [Abstract] [Full Text] [PDF]

				H. Coulom and S. Birman Chronic Exposure to Rotenone Models Sporadic Parkinson's Disease in Drosophila melanogaster J. Neurosci., December 1, 2004; 24(48): 10993 - 10998. [Abstract] [Full Text] [PDF]

				B. I. Giasson Mitochondrial Injury: A Hot Spot for Parkinsonism and Parkinson's Disease? Sci. Aging Knowl. Environ., December 1, 2004; 2004(48): pe42 - pe42. [Abstract] [Full Text]

				A. Terzi, M. Iraz, S. Sahin, A. Ilhan, N. Idiz, and E. Fadillioglu Protective effects of erdosteine on rotenone-induced oxidant injury in liver tissue Toxicology and Industrial Health, July 1, 2004; 20(6-10): 141 - 147. [Abstract] [PDF]

				E. M. Valente, P. M. Abou-Sleiman, V. Caputo, M. M. K. Muqit, K. Harvey, S. Gispert, Z. Ali, D. Del Turco, A. R. Bentivoglio, D. G Healy, et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 Science, May 21, 2004; 304(5674): 1158 - 1160. [Abstract] [Full Text] [PDF]

				J. J. Palacino, D. Sagi, M. S. Goldberg, S. Krauss, C. Motz, M. Wacker, J. Klose, and J. Shen Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice J. Biol. Chem., April 30, 2004; 279(18): 18614 - 18622. [Abstract] [Full Text] [PDF]

				S. V. Kalivendi, S. Cunningham, S. Kotamraju, J. Joseph, C. J. Hillard, and B. Kalyanaraman {alpha}-Synuclein Up-regulation and Aggregation during MPP+-induced Apoptosis in Neuroblastoma Cells: INTERMEDIACY OF TRANSFERRIN RECEPTOR IRON AND HYDROGEN PEROXIDE J. Biol. Chem., April 9, 2004; 279(15): 15240 - 15247. [Abstract] [Full Text] [PDF]

				T. B. Sherer, R. Betarbet, C. M. Testa, B. B. Seo, J. R. Richardson, J. H. Kim, G. W. Miller, T. Yagi, A. Matsuno-Yagi, and J. T. Greenamyre Mechanism of Toxicity in Rotenone Models of Parkinson's Disease J. Neurosci., November 26, 2003; 23(34): 10756 - 10764. [Abstract] [Full Text] [PDF]

				T. M. Dawson and V. L. Dawson Molecular Pathways of Neurodegeneration in Parkinson's Disease Science, October 31, 2003; 302(5646): 819 - 822. [Abstract] [Full Text] [PDF]

				J.-M. Lee, A. Y. Shih, T. H. Murphy, and J. A. Johnson NF-E2-related Factor-2 Mediates Neuroprotection against Mitochondrial Complex I Inhibitors and Increased Concentrations of Intracellular Calcium in Primary Cortical Neurons J. Biol. Chem., September 26, 2003; 278(39): 37948 - 37956. [Abstract] [Full Text] [PDF]

				M. W. I. M. Horstink and B. G. van Engelen The Effect of Coenzyme Q10 Therapy in Parkinson Disease Could Be Symptomatic Arch Neurol, August 1, 2003; 60(8): 1170 - 1172. [Full Text] [PDF]

				H.-M. Gao, B. Liu, and J.-S. Hong Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons J. Neurosci., July 16, 2003; 23(15): 6181 - 6187. [Abstract] [Full Text] [PDF]

				B. S. Han, H.-S. Hong, W.-S. Choi, G. J. Markelonis, T. H. Oh, and Y. J. Oh Caspase-Dependent and -Independent Cell Death Pathways in Primary Cultures of Mesencephalic Dopaminergic Neurons after Neurotoxin Treatment J. Neurosci., June 15, 2003; 23(12): 5069 - 5078. [Abstract] [Full Text] [PDF]

				N. Li, K. Ragheb, G. Lawler, J. Sturgis, B. Rajwa, J. A. Melendez, and J. P. Robinson Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production J. Biol. Chem., February 28, 2003; 278(10): 8516 - 8525. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help